{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:30:13Z","timestamp":1793115013591,"version":"4.5.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008757","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T13:18:27Z","timestamp":1510665507000},"page":"e8757","source":"Crossref","is-referenced-by-count":24,"title":["New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin"],"prefix":"10.1097","volume":"96","author":[{"given":"Tsubasa","family":"Takizawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenori","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-93-20210226","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"R2-93-20210226","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.icu.0000434557.30065.a7","article-title":"Neuro-ophthalmologic side-effects of systemic medications","volume":"24","author":"Pula","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"R3-93-20210226","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/neuonc\/nou001","article-title":"Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma","volume":"16","author":"Liao","year":"2014","journal-title":"Neuro Oncol"},{"key":"R4-93-20210226","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jjco\/hyv158","article-title":"Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma","volume":"46","author":"Shirai","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"R5-93-20210226","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2016.02.024","article-title":"Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy","volume":"60","author":"Zimmer","year":"2016","journal-title":"Eur J Cancer"},{"key":"R6-93-20210226","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2017.05.041","article-title":"Myasthenia gravis: an emerging toxicity of immune checkpoint inhibitors","volume":"82","author":"Makarious","year":"2017","journal-title":"Eur J Cancer"},{"key":"R7-93-20210226","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0000000000004359","article-title":"Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan","volume":"89","author":"Suzuki","year":"2017","journal-title":"Neurology"},{"key":"R8-93-20210226","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/MD.0000000000000416","article-title":"Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan","volume":"94","author":"Watanabe","year":"2015","journal-title":"Medicine"},{"key":"R9-93-20210226","doi-asserted-by":"crossref","first-page":"e2572","DOI":"10.1097\/MD.0000000000002572","article-title":"Combination of intravesical chemotherapy and Bacillus Calmette-Guerin versus Bacillus Calmette-Guerin monotherapy in intermediate- and high-risk nonmuscle invasive bladder cancer: a systematic review and meta-analysis","volume":"95","author":"Cui","year":"2016","journal-title":"Medicine"},{"key":"R10-93-20210226","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"R12-93-20210226","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Guerin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature","volume":"93","author":"Perez-Jacoiste Asin","year":"2014","journal-title":"Medicine"},{"key":"R13-93-20210226","doi-asserted-by":"crossref","first-page":"728930","DOI":"10.1155\/2011\/728930","article-title":"Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guerin and prospective use in immunotherapy of bladder cancer","volume":"2011","author":"Luo","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"R14-93-20210226","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/thoraxjnl-2011-201088","article-title":"Pulmonary complications of intravesicular BCG immunotherapy","volume":"67","author":"Davies","year":"2012","journal-title":"Thorax"},{"key":"R15-93-20210226","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1378\/chest.106.5.1624","article-title":"Granulomatous pneumonitis following intravesical BCG. What therapy is needed?","volume":"106","author":"LeMense","year":"1994","journal-title":"Chest"},{"key":"R16-93-20210226","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1212\/WNL.14.9.869","article-title":"Effect of diphenylhydantoin on neuromuscular synapse","volume":"14","author":"Norris","year":"1964","journal-title":"Neurology"},{"key":"R17-93-20210226","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJM196603032740908","article-title":"Association of trimethadione therapy and myasthenia gravis","volume":"274","author":"Peterson","year":"1966","journal-title":"N Engl J Med"},{"key":"R18-93-20210226","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archneur.1968.00470340088008","article-title":"Myasthenic syndrome associated with antibiotics","volume":"18","author":"McQuillen","year":"1968","journal-title":"Arch Neurol"},{"key":"R19-93-20210226","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-83-6-834","article-title":"Letter: beta-blockers and myasthenia gravis","volume":"83","author":"Herishanu","year":"1975","journal-title":"Ann Intern Med"},{"key":"R20-93-20210226","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.1.5958.600","article-title":"Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis","volume":"1","author":"Bucknall","year":"1975","journal-title":"Br Med J"},{"key":"R21-93-20210226","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archpsyc.1976.01770090080007","article-title":"Emergence of myasthenia gravis during treatment with lithium carbonate","volume":"33","author":"Neil","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"R22-93-20210226","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mus.880110205","article-title":"Chloroquine myopathy and myasthenia-like syndrome","volume":"11","author":"Sghirlanzoni","year":"1988","journal-title":"Muscle Nerve"},{"key":"R23-93-20210226","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mus.880130808","article-title":"Myasthenia gravis presenting as weakness after magnesium administration","volume":"13","author":"Bashuk","year":"1990","journal-title":"Muscle Nerve"},{"key":"R24-93-20210226","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2169\/internalmedicine1962.30.101b","article-title":"Bucillamine may induce myasthenia gravis","volume":"30","author":"Fujiyama","year":"1991","journal-title":"Jpn J Med"},{"key":"R25-93-20210226","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.45.2.382","article-title":"Myasthenia gravis during interferon alfa therapy","volume":"45","author":"Batocchi","year":"1995","journal-title":"Neurology"},{"key":"R26-93-20210226","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0609.1995.tb01826.x","article-title":"Myasthenia gravis following iron chelation therapy with intravenous desferrioxamine","volume":"55","author":"Krishnan","year":"1995","journal-title":"Eur J Haematol"},{"key":"R27-93-20210226","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/clinids\/22.1.175","article-title":"A clarithromycin-induced myasthenic syndrome","volume":"22","author":"Pijpers","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R28-93-20210226","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/1531-8257(200007)15:4<736::AID-MDS1023>3.0.CO;2-9","article-title":"Myasthenia gravis after botulinum toxin A for Meige syndrome","volume":"15","author":"Tarsy","year":"2000","journal-title":"Movement Disord"},{"key":"R29-93-20210226","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(02)09846-X","article-title":"Statins, fibrates, and ocular myasthenia","volume":"360","author":"Parmar","year":"2002","journal-title":"Lancet"},{"key":"R30-93-20210226","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/emj.2006.038091","article-title":"Levofloxacin induced myasthenia crisis","volume":"23","author":"Gunduz","year":"2006","journal-title":"Emerg Med J"},{"key":"R31-93-20210226","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mus.21280","article-title":"Myasthenia gravis associated with etanercept therapy","volume":"39","author":"Fee","year":"2009","journal-title":"Muscle Nerve"},{"key":"R32-93-20210226","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archinte.1997.00440250045006","article-title":"Drugs and myasthenia gravis. An update","volume":"157","author":"Wittbrodt","year":"1997","journal-title":"Arch Intern Med"},{"key":"R33-93-20210226","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.05.011","article-title":"Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine","volume":"250","author":"Poulas","year":"2012","journal-title":"J Neuroimmunol"},{"key":"R34-93-20210226","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1200\/JCO.2013.51.1683","article-title":"Myasthenia gravis induced by ipilimumab in patients with metastatic melanoma","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"R35-93-20210226","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/mus.880200501","article-title":"Unmasking and exacerbation of myasthenia gravis by ophthalmic solutions: betoxolol, tobramycin, and dexamethasone. A case report","volume":"20","author":"Khella","year":"1997","journal-title":"Muscle Nerve"},{"key":"R36-93-20210226","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00417-005-0130-4","article-title":"Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis","volume":"244","author":"Iwase","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R37-93-20210226","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/CJI.0000000000000161","article-title":"Myasthenia gravis after nivolumab therapy for squamous cell carcinoma of the bladder","volume":"40","author":"Chang","year":"2017","journal-title":"J Immunother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:42:53Z","timestamp":1620945773000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711170-00093"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":36,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008757","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}